{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:41:18Z","timestamp":1756809678755},"reference-count":39,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.04.050","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T08:52:39Z","timestamp":1241945559000},"page":"4187-4195","source":"Crossref","is-referenced-by-count":39,"title":["Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets"],"prefix":"10.1016","volume":"27","author":[{"given":"Heather L.","family":"Forrest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey M.","family":"Khalenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Govorkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March (1 (Suppl.))","key":"10.1016\/j.vaccine.2009.04.050_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1637\/7602-041306R.1","article-title":"Summary of avian influenza activity in Europe, Asia, Africa, and Australasia, 2002\u20132006","volume":"51","author":"Alexander","year":"2007","journal-title":"Avian Diseases"},{"key":"10.1016\/j.vaccine.2009.04.050_bib2","unstructured":"World Health Organization. Cumulative number of confirmed human cases of avian influenza A\/(H5N1) reported to WHO; 2008 [cited 2008 May 21]. Available from: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/country\/cases_table_2008_01_24\/en\/index.html."},{"issue":"November (21)","key":"10.1016\/j.vaccine.2009.04.050_bib3","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMp068205","article-title":"H5N1 influenza\u2014continuing evolution and spread","volume":"355","author":"Webster","year":"2006","journal-title":"The New England Journal of Medicine"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2009.04.050_bib4","first-page":"261","article-title":"Update on avian influenza A (H5N1) virus infection in humans","volume":"358","author":"Abdel-Ghafar","year":"2008","journal-title":"The New England Journal of Medicine"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2009.04.050_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMp048343","article-title":"The threat of an avian influenza pandemic","volume":"352","author":"Monto","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"May (16)","key":"10.1016\/j.vaccine.2009.04.050_bib6","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0264-410X(03)00075-6","article-title":"The role of antivirals in the control of influenza","volume":"21","author":"Monto","year":"2003","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.04.050_bib7","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1371\/journal.pmed.0040015","article-title":"Antiviral resistance and the control of pandemic influenza","volume":"4","author":"Lipsitch","year":"2007","journal-title":"PLoS Medicine"},{"issue":"November (Suppl. 2)","key":"10.1016\/j.vaccine.2009.04.050_bib8","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1086\/507552","article-title":"Antiviral management of seasonal and pandemic influenza","volume":"194","author":"Hayden","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"issue":"April (5772)","key":"10.1016\/j.vaccine.2009.04.050_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.1122665","article-title":"Predictability and preparedness in influenza control","volume":"312","author":"Smith","year":"2006","journal-title":"Science (New York, NY)"},{"issue":"February (13\u201314)","key":"10.1016\/j.vaccine.2009.04.050_bib10","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"issue":"August (9587)","key":"10.1016\/j.vaccine.2009.04.050_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"June (9272)","key":"10.1016\/j.vaccine.2009.04.050_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.04.050_bib13","first-page":"267","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nature Reviews"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.04.050_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrmicro979","article-title":"From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza","volume":"2","author":"Wood","year":"2004","journal-title":"Nature Reviews Microbiology"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2009.04.050_bib15","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"Journal of Virology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.04.050_bib16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/JVI.73.3.2094-2098.1999","article-title":"DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice","volume":"73","author":"Kodihalli","year":"1999","journal-title":"Journal of Virology"},{"issue":"August (25\u201326)","key":"10.1016\/j.vaccine.2009.04.050_bib17","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/S0264-410X(02)00268-2","article-title":"Eight-plasmid system for rapid generation of influenza virus vaccines","volume":"20","author":"Hoffmann","year":"2002","journal-title":"Vaccine"},{"issue":"April (9415)","key":"10.1016\/j.vaccine.2009.04.050_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(04)15892-3","article-title":"Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines","volume":"363","author":"Webby","year":"2004","journal-title":"Lancet"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2009.04.050_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/505225","article-title":"Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge","volume":"194","author":"Govorkova","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2009.04.050_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2009.04.050_bib21","unstructured":"Podda A, Giudice GD. MF59 adjuvant emulsion. In: Levine MM, Kaper JB, Rappuoli R, Liu MA, Good MF, editors. New generation vaccines, third ed. New York: Marcel Dekker, Inc.; 2004. p. 225\u201335."},{"issue":"April (15)","key":"10.1016\/j.vaccine.2009.04.050_bib22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0264-410X(02)00632-1","article-title":"Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A\/Duck\/Singapore\/97 vaccine in a primed human population","volume":"21","author":"Stephenson","year":"2003","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2009.04.050_bib23","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","volume":"191","author":"Stephenson","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.050_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"Journal of Biological Standardization"},{"issue":"April\u2013May (1)","key":"10.1016\/j.vaccine.2009.04.050_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0166-0934(89)90004-9","article-title":"Assessment of signs of influenza illness in the ferret model","volume":"24","author":"Reuman","year":"1989","journal-title":"Journal of Virological Methods"},{"key":"10.1016\/j.vaccine.2009.04.050_bib26","first-page":"493","article-title":"A simple method for estimating fifty percent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"American Journal of Hygiene"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.04.050_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"The Journal of Infectious Diseases"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2009.04.050_bib28","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1073\/pnas.0506416102","article-title":"Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines","volume":"102","author":"Hoffmann","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"October (159)","key":"10.1016\/j.vaccine.2009.04.050_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb01010.x","article-title":"Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections","volume":"159","author":"Doherty","year":"1997","journal-title":"Immunological Reviews"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2009.04.050_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2009.04.050_bib31","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"Journal of Immunology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.04.050_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"The New England Journal of Medicine"},{"issue":"April (20)","key":"10.1016\/j.vaccine.2009.04.050_bib33","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.vaccine.2004.11.034","article-title":"Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults","volume":"23","author":"Vandepapeliere","year":"2005","journal-title":"Vaccine"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2009.04.050_bib34","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","article-title":"Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research","volume":"25","author":"Polhemus","year":"2007","journal-title":"Vaccine"},{"issue":"September (9540)","key":"10.1016\/j.vaccine.2009.04.050_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial","volume":"368","author":"Lin","year":"2006","journal-title":"Lancet"},{"issue":"May (9523)","key":"10.1016\/j.vaccine.2009.04.050_bib36","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.04.050_bib37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/CVI.00191-06","article-title":"Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene","volume":"13","author":"Del Giudice","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.04.050_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.6.5.699","article-title":"MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection","volume":"6","author":"O\u2019Hagan","year":"2007","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.050_bib39","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T01:52:41Z","timestamp":1589766761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09006045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":39,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0264410X09006045"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}